About us at 

Creativity meets Innovation to disrupt CNS pharmacology and reignite drug discovery​

​

At Jillion Therapeutics, we're not just a biotech company; we aim to break frontiers and unlock vast, uncharted therapeutic horizons. 

 

Founded on the principles of groundbreaking science and a deep commitment to the highest experimental standards, our mission is to uncover and nurture the exceptional therapeutic potential now within our reach at Jillion.

 

​​​

Our Vision​​​​

We believed that the main "signaling highways" of the brain (dopaminergic, muscarinic, serotonergic pathways and other opioid receptors) have been overexploited over the last 6 or 7 decades and are facing their own limitations for about 1 or 2 decades now.

​

We want to transform the landscape of CNS drug discovery and pave the way for a new era of treatments for neurological diseases, with potential impact for oncology and metabolic diseases among others.

​​

​

Our Mission​

Through our proprietary High-Power Screening (HPS) technology and in-house DNA-Encoded Library (DEL) platform, we aim to rapidly and efficiently identify novel drug candidates with the potential to tackle the most challenging neurological disorders.

​​​

 

 

​
​